²é¿´: 754  |  »Ø¸´: 2
±¾Ìû²úÉú 1 ¸ö ·­ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

AnnF

°æÖ÷ (ÎÄ̳¾«Ó¢)

[ÇóÖú] ´óÉñ£¡·­ÒëÒ»¶ÎÓ¢ÎÄ£¬ÓÐÖØÐ»£¡£¡£¡

All tested compounds were dissolved in DMSO (1-100µM solution ) and subsequently diluted in the culture medium before treatment of the cultured cells . Tested cells were plated in 96-well plates at a density 2¡Á103cells /well /100mL of the proper culture me dium and treated with the compounds at 1-10 0 µM for 72 h. In parallel , the cells treated with 0 .1 % DMSO served as control . An MTT [3-(4,5-dime thylthiazol-2-yl)-2,5-diphenyl tetrazolium-bromide ] assay (Roche Molecular Biochemicals , Cat. No.11465007001) was performed 4h later according to the instructions provided by Roche. This assay was based on the cellular cleavage of MTT into formazane which is soluble in cell culture medium. Any absorbance caused by formazan was measured at595 nm with a microplate reader ( BIO-RAD , model 680 ), which is directly proportional to the number of living cells in culture. Three types of cells were used in these assays , PC3 (prostate cancer) ,BGC 823 (human gastric cancer ) and Bcap37 ( breast cancer) cell lines , provided by ATCC and cultivate din RPMI 1640 ( for PC3,BGC823 and Bcap37) supplemented with 10% fetal bovine serum. Tissue culture reagents were obtained from Gibco BRL [14] .The experiment was performed in triplicate. The percentage cytotoxicity was calculated using the formula.

Ô­ÎÄ4.jpg

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nwsuafliu

ľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
AnnF: ½ð±Ò+5, ¡ïÓаïÖú, ÓаïÖú£¬²»¹ý²»ÊǵÚÒ»¸öÓ¦ÖúµÄ 2013-01-02 16:11:54
sltmac: ½ð±Ò+10 2013-02-26 10:36:15
Â¥Éϵķ­Òë²»´í£¬Óиö±ð覴á£

ÊÔÑéËùÓû¯ºÏÎï¾ùÈܽâÓÚDMSO£¬²¢ÔÚ´¦Àíϸ°ûǰÒÔÅàÑøÒºÏ¡ÊÍ¡£ÊÔÑéϸ°ûÖÃÓÚ96¿×°å£¬ÃܶÈΪ2¡Á103ϸ°û/¿×/100uL£¬ÒÔ1-100¦ÌMµÄ»¯ºÏÎï´¦Àí72Сʱ¡£Í¬Ê±£¬ÒÔ0.1% DMSOΪ¶ÔÕÕ¡£4hºó£¬ÒÀÕÕÂÞÊϹ«Ë¾µÄÊÔ¼Á˵Ã÷½øÐÐMTT£¨3-4,5-¶þ¼×»ùàçßò-2,5-¶þ±½»ùËĵªßòäåÑΣ¬àçßòÀ¶£©²â¶¨£¨ÂÞÊϹ«Ë¾£¬ÊÔ¼ÁºÅ11465007001£©¡£MTT²â¶¨Ô­Àí»ùÓÚMTT±»Ï¸°û·Ö½âΪϸ°ûÅàÑø»ùÖпÉÈܵļ×è¶¡£¼×è¶µÄÎü¹â¶È¿ÉÒÔÓÃø±êÒÇ£¨BIO-RAD£¬680ÐÍ£©ÔÚ595nmϲâµÃ£¬ËüºÍÅàÑøÖеĻîϸ°ûÊý³ÉÕý±È¡£ÈýÖÖϸ°û±»ÓÃÓÚ¸ÃÊÔÑ飬¼´PC3£¨Ç°ÁÐÏÙ°©£©¡¢BGC823£¨ÈËθ°©£©ºÍBcap37£¨ÈéÏÙ°©£©Ï¸°ûϵ¡£ÕâЩϸ°ûÖêÓÉATCC£¨ÃÀ¹ú¾úÖÖ±£´æÖÐÐÄ£©Ìṩ£¬ÒÔº¬ÓÐ10£¥Ì¥Å£ÑªÇåµÄRPMI 1640ÅàÑøÒºÅàÑø¡£×éÖ¯ÅàÑøÊÔ¼Á¹ºÓÚGibco BRL¹«Ë¾[14]£¬Ã¿×éʵÑéÉè3´ÎÖØ¸´¡£ÀûÓÃÒÔϹ«Ê½¼ÆËãϸ°û¶¾ÐԵİٷÖÂÊ¡£
ϸ°û¶¾ÐÔ% =100 x [ (¶ÔÕÕÎü¹âÖµ-¿Õ°×Îü¹âÖµ)-£¨²âÊÔÎü¹âÖµ-¿Õ°×Îü¹âÖµ£©]/£¨¶ÔÕÕÎü¹âÖµ-¿Õ°×Îü¹âÖµ£©
֪ʶ¸Ä±äÃüÔË
3Â¥2013-01-02 16:03:55
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 3 ¸ö»Ø´ð

²Ý¶ùÇàÇà

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

С±ø

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
AnnF: ½ð±Ò+10, ·­ÒëEPI+1, ¡ïÓаïÖú, »¹¿ÉÒÔ£¬Ð»Ð» 2013-01-02 16:11:35
sltmac: ½ð±Ò+10 2013-02-26 10:36:10
ËùÓÐÓÃÓÚʵÑéµÄ»¯ºÏÎïÈܽâÓÚDMSOÖУ¬ÔÚ×÷ÓÃϸ°ûǰÓÃÅàÑøÒºÏ¡ÊÍ¡£½«Ï¸°ûÖÖÖ²ÔÚ96¿×°å£¬ÃܶÈΪ2¡Á103ϸ°û/¿×/100uL£¬¼ÓÈë1-100¦ÌM»¯ºÏÎ×÷ÓÃ72Сʱ´¦Àí¡£Í¬Ê±£¬ÒÔ¼Ó0.1% DMSOµÄ×÷Ϊ¶ÔÕÕ×é¡£4hºó£¬ÒÀÕÕÊÔ¼Á˵Ã÷½øÐÐMTT£¨3-4,5-¶þ¼×»ùàçßò-2,5-¶þ±½»ùËĵªßòäåÑΣ¬àçßòÀ¶£©ÊµÑ飨ÂÞÊϹ«Ë¾£¬ÊÔ¼ÁºÅ11465007001£©¡£±¾ÊµÑé»ùÓÚ»îϸ°û¿ÉÒÔ½«MTT·Ö½âΪ¿ÉÈÜÐԵļ×è¶¡£¼×è¶µÄÎü¹â¶È¿ÉÒÔÓÃø±êÒÇ£¨BIO-RAD£¬680ÐÍ£©ÔÚ595nmϲâµÃ£¬ËüͬÅàÑøµÄ»îϸ°ûµÄÊýÄ¿³ÉÕý±È¡£ÈýÖÖϸ°û±»ÓÃÓÚ´ËʵÑ飬PC3£¨Ç°ÁÐÏÙ°©£©£¬BGC823£¨ÈËθ°©£©ºÍBcap37£¨ÈéÏÙ°©£©Ï¸°ûϵ£¬Ï¸°ûÖêÓÉATCC£¨ÃÀ¹ú¾úÖÖ±£´æÖÐÐÄ£©Ìṩ£¬ÒÔº¬ÓÐ10£¥Ì¥Å£ÑªÇåµÄRPMI 1640ÅàÑøÒºÅàÑø¡£×éÖ¯ÅàÑøÊÔ¼Á¹ºÓÚGibco BRL¹«Ë¾[14]£¬Ã¿×éʵÑéÓÐÈý·õ¿×¡£ÀûÓÃÏÂÁй«Ê½¼ÆËãϸ°û¶¾ÐԵİٷÖÂÊ¡£
ÓÆÓÆ
2Â¥2013-01-02 07:33:40
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á +10 īīĮ 2026-03-18 11/550 2026-03-20 11:57 by ѧԱ8dgXkO
[¿¼ÑÐ] Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á +11 Ymlll 2026-03-18 14/700 2026-03-20 10:46 by EBSD
[¿¼ÑÐ] 295²ÄÁÏÇóµ÷¼Á£¬Ò»Ö¾Ô¸Î人Àí¹¤085601ר˶ +3 Charlieyq 2026-03-19 3/150 2026-03-20 08:53 by xingguangj
[¿¼²©] É격26Äê +3 °Ë6°Ë68 2026-03-19 3/150 2026-03-19 19:43 by nxgogo
[¿¼ÑÐ] 085601²ÄÁϹ¤³Ìר˶Çóµ÷¼Á +10 Ľº®mio 2026-03-16 10/500 2026-03-19 15:26 by ¶¡¶¡*
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤Çóµ÷¼Á +7 Ϊѧ666 2026-03-16 7/350 2026-03-19 14:48 by ¾¡Ë´Ò¢1
[¿¼ÑÐ] »¯Ñ§Çóµ÷¼Á +3 ÁÙÔó¾³llllll 2026-03-17 4/200 2026-03-19 13:59 by houyaoxu
[½Ìʦ֮¼Ò] ½¹ÂÇ +9 Ë®±ùÔÂÔÂÒ°Íà 2026-03-13 13/650 2026-03-19 09:50 by otani
[¿¼ÑÐ] 354Çóµ÷¼Á +4 Tyoumou 2026-03-18 7/350 2026-03-18 21:45 by Tyoumou
[¿¼ÑÐ] 344Çóµ÷¼Á +6 knight344 2026-03-16 7/350 2026-03-18 20:13 by walc
[¿¼ÑÐ] 311Çóµ÷¼Á +6 26ÑÐ0 2026-03-15 6/300 2026-03-18 14:43 by haxia
[¿¼ÑÐ] 297Çóµ÷¼Á +8 Ï·¾«µ¤µ¤µ¤ 2026-03-17 8/400 2026-03-18 14:30 by laoshidan
[¿¼ÑÐ] 302Çóµ÷¼Á +10 ºôºôºô¡£¡£¡£¡£ 2026-03-17 10/500 2026-03-18 12:45 by Linda Hu
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +3 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 3/150 2026-03-18 10:12 by macy2011
[¿¼ÑÐ] 268Çóµ÷¼Á +8 Ò»¶¨ÓÐѧÉÏ- 2026-03-14 9/450 2026-03-17 17:47 by laoshidan
[¿¼ÑÐ] 302Çóµ÷¼Á +4 С¼Öͬѧ123 2026-03-15 8/400 2026-03-17 10:33 by С¼Öͬѧ123
[¿¼ÑÐ] 070303 ×Ü·Ö349Çóµ÷¼Á +3 LJY9966 2026-03-15 5/250 2026-03-16 14:24 by xwxstudy
[¿¼ÑÐ] 0856Çóµ÷¼Á +3 ÁõÃÎ΢ 2026-03-15 3/150 2026-03-16 10:00 by houyaoxu
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¹¤´ó²ÄÁÏ324·ÖÇóµ÷¼Á +5 ãÆÐñ¶« 2026-03-14 5/250 2026-03-14 14:53 by ľ¹Ï¸à
[¿¼ÑÐ] 311Çóµ÷¼Á +3 ¶¬Ê®Èý 2026-03-13 3/150 2026-03-13 20:41 by JourneyLucky
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û